Bring the wanting back
Works on the brain circuits behind desire, so interest may show up on its own instead of being talked into.
Desire
A prescription nasal spray that works on desire, not blood flow. It acts on the brain pathways involved in wanting to, which the pills don't touch.
Plain packaging. No insurance needed. Nothing charged unless prescribed.
Important safety informationPT-141 is the peptide bremelanotide. It activates melanocortin receptors in the brain, the signaling system involved in sexual desire. An injectable form of the same molecule is FDA-approved for low sexual desire in women. Faber's is a compounded nasal spray from a U.S. state-licensed pharmacy, prescribed off-label after a clinician reviews your intake, including for men. It is not FDA-approved.
One spray about 45 minutes to an hour before intimacy. It works per use, not as a daily course, and your clinician sets the dose and how often you can use it.
[$P] per bottle, including clinician review, supervision and shipping. No insurance needed.
Works on the brain circuits behind desire, so interest may show up on its own instead of being talked into.
Acts above the neck, not on blood flow. Many men describe arousal that arrives without effort, and stays when it does.
No performance clock, no planning a week ahead. One spray, then let it happen. Some men pair it with a pill for the mechanics.
Two different problems. Faber treats both, with different tools.
PT-141
Works in the brain, on the pathways behind desire. For men who can perform but don't feel like it.
The pills
Work on blood flow, below the waist. For men who feel like it but can't rely on the response. See the Sexual health protocol.
Some men use both, under clinician guidance. Your clinician decides what belongs in your protocol.
PT-141 switches on melanocortin receptors in the part of the brain that regulates sexual motivation. Those receptors sit upstream of two signals you've heard of: dopamine, the wanting signal, and oxytocin, the closeness signal. Research on how much each contributes is still mostly early-stage, but it's why men describe the effect as interest rather than a mechanical response.
What they noticed
Took it about an hour before and just noticed I was actually into it. Not a switch, more like the interest was back.
Marcus T. · layout sample
I already had the pills for the other part. This covered the part they never did. Combined, under the doctor's guidance, it's a different evening.
Daniel R. · layout sample
Spray, no needle, no planning a week ahead. Easy to fit in, easy to skip when I don't need it.
Jonah K. · layout sample
Answer a few questions
About your health and goals, online, takes about 10 minutes.
Get a clinician's review
A U.S.-licensed clinician reviews within 48 hours. Your card is held, not charged.
Receive your protocol
If prescribed, payment goes through and your protocol & medicine ships within a few days.
PT-141 works on wanting. Oxytocin works on closeness. Many protocols run both; your clinician decides what fits.
Both are compounded by a U.S. state-licensed pharmacy with regular independent batch testing, and are not FDA-approved. Your clinician decides which belongs in your protocol.
The desire mechanism is well established: an injectable form of this molecule is FDA-approved for low sexual desire in women, and its effect was shown in the trials behind that approval. Large trials of the nasal spray, and formal trials in men, don't yet exist; use in men rests on shared biology, earlier research that included men, and clinical experience. Responses are individual: some men report a clear change, others a moderate one. Your clinician sets your dose and adjusts it with you based on how you respond.
The pathways it acts on are the same in both sexes, and clinicians have prescribed it off-label to men for years. Formal trial data in men are limited, so your own response over several uses is the measure that matters. Your clinician helps you judge that.
Often, yes. PT-141 works on desire, the pills on blood flow, and some men need both. Your clinician advises on combinations and timing; don't combine on your own.
Convenience. The FDA-approved form is an autoinjector; compounding pharmacies make the spray for people who'd rather skip the needle. The spray hasn't been through its own large trials, which is part of why clinician oversight comes with it.
Different molecule, different manufacturing. The pills are mass-produced generics; PT-141 is a compounded peptide from a U.S. state-licensed pharmacy with regular independent batch testing, and the price includes clinician review and supervision.
Nothing to unwind. It's used per episode, not continuously; no dependence, no taper, no rebound. Use it when you want its effect.
PT-141 (bremelanotide) nasal spray is a compounded medication and is not FDA-approved. It is prescribed off-label. Use only the dose your clinician sets, no more than one dose in 24 hours, and no more than the monthly limit your clinician gives you. The most common side effect is nausea; flushing, headache and nasal irritation are also common. Each dose can cause a small, temporary rise in blood pressure, so do not use if you have uncontrolled high blood pressure or known cardiovascular disease. With frequent use, some people notice darkening of patches of skin, gums or freckles. Tell your clinician about all medications you take. This is not a complete list; your clinician will review risks with you.
A vetted clinician reviews your health history and decides on prescription.
Carefully selected state-licensed & state-inspected with regular testing.
Encrypted and handled under HIPAA & SOC-2.
All partners are audited by an independent third party company.